Egis follows the applicable pharmaceutical self-regulatory codes and consequently Egis must document and disclose on its website all engagements and transfers which it provides, either directly or indirectly, to or with a view to a healthcare professional, healthcare organisation or a patient organisation. For further details, please visit the national websites of the Egis subsidiaries.

Disclosure of Supports/Sponsorships to Patient Organisations  (Code of Ethics for Pharmaceutical Marketing Communications) Further information:

Ethical standards to be followed by Egis

The amended Code of Ethics for Pharmaceutical Communications signed by the four Hungarian pharmaceutical manufacturers' association came into force on 1 July 2017. The aim of establishing the code was to ensure the highest level of protection of patients’ interests, and to ensure that the most stringent rules are in place for the pharmaceutical actors themselves. Further information:

Code of Ethics of the Servier Group: Ethical charter

Code of Conduct of the Servier Group: Code of Conduct 

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox